UK dividends calendar - next 7 days
30th Oct 2026 14:35
| Price | 1,109.00p on 30-10-2026 at 15:03:05 |
|---|---|
| Change | -12.00p -1.07% |
| Buy | 1,109.50p |
| Sell | 1,108.50p |
| Last Trade: | Buy 146.00 at 1,109.00p |
| Day's Volume: | 2,451,145 |
| Last Close: | 1,121.00p |
| Open: | 1,108.00p |
| ISIN: | GB0009223206 |
| Day's Range | 1,088.00p - 1,118.50p |
| 52wk Range: | 980.40p - 1,426.50p |
| Market Capitalisation: | £9.28b |
| VWAP: | 1,106.32726p |
| Shares in Issue: | 837.03m |
Smith & Nephew (SN.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 146 | 1,109.00p | Automatic Execution |
15:02:32 - 30-Oct-26 |
| Buy* | 333 | 1,108.50p | Automatic Execution |
15:02:23 - 30-Oct-26 |
| Buy* | 113 | 1,108.50p | Automatic Execution |
15:02:23 - 30-Oct-26 |
| Buy* | 246 | 1,108.50p | Automatic Execution |
15:02:11 - 30-Oct-26 |
| Unknown* | 100 | 1,108.50p | SI Trade |
15:02:09 - 30-Oct-26 |
| Buy* | 573 | 1,108.00p | Automatic Execution |
15:02:08 - 30-Oct-26 |
| Sell* | 226 | 1,107.50p | Automatic Execution |
15:02:08 - 30-Oct-26 |
| Buy* | 333 | 1,107.50p | Automatic Execution |
15:02:08 - 30-Oct-26 |
| Buy* | 323 | 1,107.50p | Automatic Execution |
15:02:08 - 30-Oct-26 |
| Buy* | 965 | 1,107.50p | Automatic Execution |
15:02:08 - 30-Oct-26 |
Smith & Nephew (SN.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Oct 2026 10:25 am | RNS | Sterling Amount of Dividend |
| 8th Oct 2026 2:27 pm | RNS | Notice of Results |
| 1st Oct 2026 10:03 am | RNS | Total Voting Rights |
| 1st Oct 2026 7:00 am | RNS | Redemption Price of $350m 5.150% Notes due 2027 |
| 18th Sep 2026 2:29 pm | RNS | Admission to Trading |
| 18th Sep 2026 7:00 am | RNS | Redemption of $350m 5.150% Notes due 2027 |
| 16th Sep 2026 10:15 am | RNS | Result of cash tender offer for 2030 bonds |
| 16th Sep 2026 7:00 am | RNS | Pricing of cash tender offer for 2030 bonds |
| 10th Sep 2026 7:00 am | RNS | Smith+Nephew Prices USD Bond Issue |
| 9th Sep 2026 9:29 am | RNS | Director/PDMR Shareholding |